Akcea and Ionis Complete Licensing Transaction to Commercialize Inotersen for hATTR Pharmaceutical Investing
Cesca Therapeutics Announces First Evaluation Agreement With a Leading U.S. Academic Research Institution for X-Series Products That Provide Automated, Closed System Cellular Processing Biotech Investing
VBI Vaccines Announces Positive DSMB Review in Phase 1/2a Study of VBI-1901 in Recurrent Glioblastoma (GBM) Patients Pharmaceutical Investing
Anavex Life Sciences to Initiate Phase 2 Study of ANAVEX®2-73 in Parkinson’s Disease Dementia Pharmaceutical Investing
Basilea licenses late-stage oncology drug candidate derazantinib from ArQule Pharmaceutical Investing
Lexaria Achieves Significant Breakthrough in Alternative Nicotine Delivery Technology Cannabis Investing News
New Preclinical Studies Reinforce the Potential for Heightened Anti-Cancer Activity of Combination Therapies Based on Immunovaccine’s Proprietary Delivery Platform Biotech Investing
